Abstract
Thrombotic thrombocytopenic purpura (TTP) is a kind of thrombotic microangiopathies which has low incidence but highly mortality. The outcome of TTP has been improved significantly since last decade due to the application of plasma exchange, however, early relapse occurs in some patients, and for relapsed/refractory patients the prognosis is still poor. This article reviews the recent progress in treatment and relevant influencing factors of TTP. Key words: Thrombotic thrombocytopenic purpura; Treatment
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
